Skip to Content
Morningstar
Get 14 Days Free

Procter & Gamble Co PG

Morningstar Rating
Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Stewardship

PREMIUM

P&G Continues to Clean Up, but Valuation Is Far From a Bargain

Erin Lash, CFA Sector Director

Analyst Note

| Erin Lash, CFA |

It wasn’t that long ago when wide-moat Procter & Gamble was dogged quarter-after-quarter for boasting lackluster revenue growth; however, with the company posting its eighth consecutive quarter and second consecutive year of mid-single-digit organic revenue growth, we don’t think these concerns are top of mind for investors at this juncture (with shares up more than 2% on the print). We attribute this staunch performance to its radical decision six years ago to materially prune its brand mix (cutting more than 100, leaving it with just 65) and focus its resources on its highest return opportunities as a means to more nimbly respond to evolving consumer trends.

Read Full Analysis

Company Profile

Business Description

Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating more than $70 billion in annual sales. It operates with a lineup of leading brands, including 21 that generate more than $1 billion in annual global sales such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. P&G sold its last remaining food brand, Pringles, to Kellogg in calendar 2012. Sales outside its home turf represent around 55% of the firm's consolidated total, with around one third coming from emerging markets.

Contact
One Procter and Gamble Plaza
Cincinnati, OH, 45202
T +1 513 983-1100
Sector Consumer Defensive
Industry Household & Personal Products
Most Recent Earnings Jun 30, 2020
Fiscal Year End Jun 30, 2021
Stock Type High Yield
Employees 99,000

Related

Investing Specialists
Our Ultimate Stock Pickers' Top 10 Dividend-Yielding Stocks
Many of the highest-yielding names are undervalued today.
Nupur Balain
Investing Specialists
Our Ultimate Stock-Pickers' Top 10 Buys and Sells
Funds focus purchases in basic materials and consumer sectors.
Nupur Balain
US Videos
Where to Invest for Income
A raft of companies have cut their dividends this year, leaving income investors concerned. But Morningstar's Dan Lefkovitz says there are still plenty of options out there.
Dan Lefkovitz
Investing Specialists
Our Ultimate Stock-Pickers' Top 10 High-Conviction Purchases
Several funds see value in basic materials and communication services
Nupur Balain
ETF Specialist
Value Investing Revisited
The methods may need fine-tuning, but fundamentals still drive returns.
Alex Bryan
Stock Analyst Update
P&G Continues to Clean Up in Q2; Valuation No Bargain
We think the company has the wherewithal to withstand impending pressures.
Erin Lash
Market Update
Who’s Growing Dividends in Today’s Market?
Morningstar indexes spotlight rising equity income streams.
Dan Lefkovitz
Commentary
The Week Ahead: Pfizer, Facebook, Google, and Apple to Report Earnings
Earnings from big names in industrials, consumer cyclical, finance, and more are also on the calendar for next week.
Carole Hodorowicz
Market Update
Growth Parties Like It's 1999, but Don't Rule Out Value
Morningstar style indexes reveal market divergence and opportunity.
Dan Lefkovitz
Fund Spy
This Vanguard Dividend Fund Still Solid Despite Downgrade
Silver-rated Vanguard Dividend Appreciation provides investors with a diversified portfolio of highly profitable U.S. dividend-paying stocks.
Venkata Sai Uppaluri
Stock Analyst Update
P&G Weathers COVID-19, but a Storm Still Lies Ahead
We don't expect to alter our fair value estimate or long-term outlook for the wide-moat firm, but we think investors should await a more attractive risk/return opportunity.
Erin Lash
Our Picks
16 Solid Stocks During Rocky Times
This shortlist of high-quality companies with predictable cash flows and modest leverage are well-equipped for today’s market uncertainty.
Susan Dziubinski
Fund Spy
2019: A Strong Year for Income Assets, Less So for Some Income Funds
A volatile end to 2018 resulted in an overly conservative positioning going into 2019.
Patricia Oey
Fund Spy
Fund Ideas for the New Decade
Value funds plus big upgrades are worth a look.
Russel Kinnel
Stock Strategist
Although Its Upward Sales Trajectory Persists, Procter & Gamble's Shares Fail to Offer a Bargain
We are maintaining our $106 FVE.
Erin Lash
Stock Analyst Update
Upward Sales, but Procter & Gamble Shares No Bargain
We believe investors should await a more favorable entry point before buying shares of this wide-moat firm.
Erin Lash
Commentary
The Week Ahead: Abbott Laboratories and Johnson & Johnson Due
Fourth-quarter earnings announcements from financial, consumer products, and technology sectors.
Charlotte Frank
Rekenthaler Report
The Strange and Happy Tale of Voya Corporate Leaders Trust
A fund that shouldn’t succeed, but does.
John Rekenthaler
ETF Specialist
This Quality Dividend-Growth ETF Looks to the Future
This strategy effectively targets firms that should have the capacity to raise their dividends in the future.
Alex Bryan
Stock Analyst Update
Tide Has Turned on P&G's Sales Course, Shares Pricey
Wide-moat Procter & Gamble chalked up another quarter of strong sales and profit gains.
Erin Lash